Publishers Alliance

Breast Cancer: Targets and Therapy

Bortezomib-based vs non-bortezomib-based post-transplantation treatment in multiple myeloma patients: a systematic review and meta-analysis of Phase III randomized controlled trials

[Oncotargets and Therapy] This research examines the efficacy and safety of bortezomib-based vs non-bortezomib-based post-transplantation therapy in patients with multiple myeloma.

Next post in Publishers Alliance